Extended Caffeine for Apnea in Moderately Preterm Infants
This randomized clinical trial assessed whether extended use of caffeine after its planned discontinuation through 28 days after discharge among moderately preterm infants would decrease the number of days in the hospital compared with infants receiving placebo.
This randomized clinical trial assessed whether extended use of caffeine after its planned discontinuation through 28 days after discharge among moderately preterm infants would decrease the number of days in the hospital compared with infants receiving placebo.
